Holen Sie sich die Stockscreener-App
231.00
0.43%
1.0175
Natera Inc Aktie (NTRA) Neueste Nachrichten
Natera, Inc. (NASDAQ:NTRA) Short Interest Update - MarketBeat
Medical stock hovers near buy point after 46% gain - MSN
Medical Stock Hovers Near Buy Point After 46% Gain - Investor's Business Daily
Reproductive Genetics Market Size to Reach USD 16.67 Billion in 2032 Amid Increasing Demand for Genetic Testing - GlobeNewswire Inc.
Analysts Are Bullish on These Healthcare Stocks: Natera (NTRA), Immunome (IMNM) - The Globe and Mail
Vontobel Holding Ltd. Increases Stock Position in Natera, Inc. $NTRA - MarketBeat
Natera is Transforming Patient Care Using AI - Amazon Web Services (AWS)
Natera: Is Signatera’s Momentum About to Accelerate Again as Biomarker Laws Expand State by State? - Smartkarma
Natera, Inc. $NTRA Shares Bought by SWS Partners - MarketBeat
Is Natera’s 486% Three Year Surge Still Justified by Its Fundamentals? - Yahoo Finance
3 Reasons We’re Fans of Natera (NTRA) - Barchart.com
3 Reasons We're Fans of Natera (NTRA) - Finviz
J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum - Finviz
Natera co-founder Sheena Jonathan sells $338913 in stock By Investing.com - Investing.com Nigeria
Natera co-founder Sheena Jonathan sells $338913 in stock - Investing.com
Canaccord Genuity Maintains Natera (NTRA) Buy Recommendation - Nasdaq
Natera (NTRA): Revisiting Valuation After New JAMA Oncology Data on Signatera’s Colorectal Cancer Benefit - simplywall.st
Natera (NASDAQ:NTRA) Price Target Raised to $285.00 - MarketBeat
Natera to Participate in the 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com
Will Natera Inc. stock outperform tech sector in 2025July 2025 Analyst Calls & Real-Time Volume Analysis Alerts - ulpravda.ru
How Natera Inc. stock performs in stagflationMarket Weekly Review & Precise Entry and Exit Recommendations - ulpravda.ru
Zevenbergen Capital Investments LLC Sells 11,417 Shares of Natera, Inc. $NTRA - MarketBeat
Natera (NTRA): Assessing Valuation After a Multi‑Year Share Price Surge - Yahoo Finance
Natera, Inc. $NTRA Shares Bought by Orion Porfolio Solutions LLC - MarketBeat
Did Strong New Signatera ctDNA Data Just Shift Natera’s (NTRA) Investment Narrative? - simplywall.st
How Investors Are Reacting To Natera (NTRA) Trial Data Showing Signatera’s 40% Risk Reduction In CRC - Yahoo Finance
Dir Sheena Files To Sell 4,500 Of Natera Inc [NTRA] - TradingView — Track All Markets
Can Natera Inc. stock beat analyst upgradesJuly 2025 Snapshot & Weekly High Return Opportunities - DonanımHaber
Is Natera’s 425.8% Three Year Surge Still Supported by Its Growth Story in 2025? - simplywall.st
Is Natera Inc. stock a safe buy before earningsQuarterly Profit Summary & Weekly High Conviction Trade Ideas - Улправда
Profit Recap: Will Natera Inc. stock outperform tech sector in 20252025 Biggest Moves & Growth Focused Entry Point Reports - Улправда
NTRA: Natera's Phase III Study Highlights Celecoxib's Efficacy i - GuruFocus
Study shows celecoxib improves survival in certain colorectal cancer patients - Investing.com India
Natera Announces Publication of Signatera™ Analysis from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study in Colorectal Cancer - New Castle News
Is Natera Inc. stock attractive after correctionJuly 2025 Opening Moves & Weekly Chart Analysis and Guides - Улправда
Thrivent Financial for Lutherans Cuts Stake in Natera, Inc. $NTRA - MarketBeat
Assenagon Asset Management S.A. Purchases 80,684 Shares of Natera, Inc. $NTRA - MarketBeat
Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Natera (NTRA) - The Globe and Mail
Natera (NTRA) director and co-founder discloses stock gift and sales - Stock Titan
Dir Sheena Sells 3,070 ($696.9K) Of Natera Inc [NTRA] - TradingView — Track All Markets
Natera’s Signatera Test Gains Validation in Key Breast Cancer Study - AD HOC NEWS
Dir Sheena Files To Sell 9,210 Of Natera Inc [NTRA] - TradingView — Track All Markets
Natera, Inc.'s (NASDAQ:NTRA) Business Is Trailing The Industry But Its Shares Aren't - 富途牛牛
Solomon Moshkevich Sells 4,692 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Insider Selling: Natera (NASDAQ:NTRA) Director Sells 48,419 Shares of Stock - MarketBeat
Officer Moshkevich Acquires 17,684 Of Natera Inc [NTRA] - TradingView — Track All Markets
Dir Rosenman Sells 48,419 ($11M) Of Natera Inc [NTRA] - TradingView — Track All Markets
NATERA INC : JEFFERIES RAISES TARGET PRICE TO $275 FROM $230 - 富途牛牛
Natera’s cancer test improves risk assessment in breast cancer patients By Investing.com - Investing.com Nigeria
Natera’s cancer test improves risk assessment in breast cancer patients - Investing.com
Natera, Inc. $NTRA Shares Bought by New England Research & Management Inc. - MarketBeat
Natera (NASDAQ: NTRA) I-SPY 2 study ties Signatera ctDNA status to 3-year DRFS, recurrence risk - Stock Titan
NeoGenomics (NEO): Assessing Valuation After Legal Win Over Natera and New Oncology Data Releases - simplywall.st
Jefferies raises Natera stock price target to $275 on oncology growth - Investing.com Nigeria
Here's How Much $1000 Invested In Natera 10 Years Ago Would Be Worth Today - Sahm
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):